By: The ASCO Post Staff From: ascopost.com Women who develop gestational diabetes may not have a higher likelihood of being diagnosed with breast cancer, according to recent findings that will be presented by Christensen et al at the upcoming European Association for the Study of Diabetes Annual Meeting 2024 (Abstract 180). Background Gestational diabetes affects 14% of pregnant women globally …
Clinical trials excluding fewer cancer patients with brain ‘mets’
By: Diane Mapes From: fredhutch.org Fred Hutch’s health services researcher Joe Unger, PhD, MS, working with the American Society of Clinical Oncology (ASCO), the U.S. Food & Drug Administration (FDA) and the Friends of Cancer Research, published a study last week that found clinical trials have started to modify eligibility criteria to be more inclusive of patients with brain metastasis, …
SIO and ASCO recommend mindfulness-based interventions for anxiety, depression in cancer patients
Source: The Reis Grou From: news-medical.net The Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO) formally recommend mindfulness-based interventions (MBIs) and other integrative therapies to manage anxiety and depression symptoms in adults living with cancer. The guideline, published in the Journal of Clinical Oncology, reviews the effectiveness of integrative therapies such as yoga, relaxation, hypnosis, …
Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery
From: newswire.com A recent peer-reviewed study published in the American Journal of Clinical Oncology demonstrates tumor bed delineation superiority of Videra Surgical’s VeraForm® marker versus surgical clips for targeting breast cancer radiotherapy treatment following breast-conserving surgery. Post-surgical radiation therapy is a typical treatment course for many breast cancer patients undergoing lumpectomy. Accurate position and shape of the tumor bed is …
Healio roundup: Top coverage in breast cancer from ASCO 2022
By: Isabella Hornick From: healio.com Healio rounded up the top breast cancer coverage presented and discussed at ASCO Annual Meeting in Chicago. The top story in breast cancer was a presentation that demonstrated the possibility of safe avoidance of radiotherapy following breast-conserving surgery among older patients with low-grade luminal A breast cancer. According to Timothy Joseph Whelan, MD, FASCO, professor …
Rapid Update to ASCO Breast Cancer Guidelines After OlympiA Data
By: Sharon Worcester From: medscape.com The American Society of Clinical Oncology (ASCO) now recommends offering 1 year of adjuvant olaparib therapy to patients with early-stage HER2-negative, BRCA-mutated breast cancer who have completed chemotherapy and local treatment. The change in management of hereditary breast cancer is outlined in an update to 2020 guidelines, and it comes as a “rapid recommendation” on …
Digital Assistant powered by Lifelink Systems deployed, providing on-demand breast cancer education for patients
From: prweb.com Lifelink Systems today announced that its conversational technology platform is live, powering a digital FAQ chatbot on Cancer.Net, the patient information website of the American Society of Clinical Oncology (ASCO®). The medical information technology solution provides doctor-approved information about breast cancer for patients, caregivers, and health care professionals. ASCO represents nearly 45,000 oncology professionals who care for people …
Assessing Biomarkers in Metastatic Breast Cancer
By: Kate M. O’Rourke From: medscape.com Growing evidence demonstrates that changes in biomarker status occur frequently during the metastatic progression of breast cancer and can affect treatment response. “When a woman is first diagnosed with metastatic disease, it is important to reevaluate markers, because these do occasionally change from the time of primary diagnosis.” says Eric Winer, MD, a medical …
ASCO develops guideline for management of men with breast cancer
By: Jennifer Byrne From: healio.com Research has led to major improvements in breast cancer diagnosis, treatment and survival. However, men with breast cancer represent only 1% of the U.S. breast cancer population and have not been emphasized in this research. “Nearly all clinical trial participants have been women,” Michael J. Hassett, MD, MPH, medical oncologist at Dana-Farber Cancer Institute and …
Biomarkers for Early-Stage Invasive Breast Cancer Clinical Practice Guidelines (ASCO, 2019)
Source: American Society of Clinical Oncology From: medscape.com The American Society of Clinical Oncology (ASCO) published recommendations on the use of biomarkers for decision making regarding adjuvant systemic treatment for women with early-stage invasive breast cancer in April 2016.[1] In August 2017 and August 2019, ASCO released focused updates of these guidelines.[2,3] The combined recommendations are summarized below. ASCO advises …